Accelerate to discover
Related topics
Successful migration from radioactive irradiators to x-ray irradiators
Dec 9, 2019
This paper summarizes about 9 years of effort by Mount Sinai to successfully migrate completely from radioactive...
New NovoCyte Advanteon - Performance you can trust with the flexibility you need
Dec 6, 2019
The NovoCyte Advanteon flow cytometer builds upon the highly successful NovoCyte, and NovoCyte Quanteon, to provide an...
Bioflux webinar: Flow dynamics influence on biofilm formation by Proteus mirabilis
Dec 2, 2019
Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...
Bruker MRI consistent quantification
Nov 29, 2019
Regardless of the method, stability and reproducibility are a must for many laboratories. Identical protocols must...
Targeted sequencing of highly homologous genes using Cas9 digestion
Nov 25, 2019
Integrated DNA extraction, digestion, and size-selection using HLS-CATCH were introduced for addressing the problem of...
Multirad - Fully integrated x-ray irradiation system
Nov 20, 2019
The new X-RAD 160 qube is suitable for either mounting on the lab bench or mobile on an optional wheeled cart, allowing...
AVATAR system: A unique capability for functional screening of tumor microenvironment
Nov 18, 2019
The AVATAR Cell Control System lets you generate your cells of interest and optimize to a growth rate, functional...
Nov 14, 2019
Today watch this interesting video interview with Anabela Bensimon-Brito, Department of Developmental Genetics, Max...
Oct 24, 2019
Trough this study we have seen that CF33 and CF33-Fluc are safe and efective in vitro and in vivo. Trough chimerization and high throughput screening, the novel virus have been created that requires lower doses to treat pancreatic cancer in a preclinical model. CF33-Fluc replication in non-injected, distant tumors halted tumor growth. Further studies in immune-competent models investigating the mechanisms of rapid tumor regression and viral spread to non-injected tumors following a low viral dose will enhance our understanding of how this novel virus targets and kills pancreatic cancer.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Get more info
Brand profile
Spectral Instruments Imaging manufactures instruments for preclinical optical (bioluminescent, fluorescent) and X-ray imaging.
More info at:
https://specimg.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
